Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

    Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca
    e2024042
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.042
    4074
    PDF: 1576
    HTML: 932
  • PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

    Giuseppe G.M. Leone, Ugo Testa
    e2025080
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.080
    1008
    PDF: 343
    Html: 96
  • CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

    Ugo Testa, Elvira Pelosi, Dr. Germana Castelli
    e2024077
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.077
    1701
    PDF: 830
    HTML: 142
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5246
    PDF: 1910
    HTML: 1351
  • IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE

    Francesco Di Raimondo, Giorgio La Nasa
    e2014039
    2014-05-29
    https://doi.org/10.4084/mjhid.2014.039
    2207
    PDF: 957
    HTML: 1889
  • MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

    Davide Matino, Paul Tieu, Dr., Antony Chan
    e2020001
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.001
    3216
    PDF: 1608
    HTML: 422
  • EBV IN HODGKIN LYMPHOMA

    Giuseppina Massini, Doerte Siemer, Stefan Hohaus
    e2009013
    https://doi.org/10.4084/mjhid.2009.013
    1640
    PDF: 596
    HTML: 13933
  • LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B

    Eva Eliassen, Gerhard R Krueger, Mario Luppi, Dharam Ablashi
    e2018035
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.035
    3742
    PDF: 1465
    HTML: 482
    Figures . Eliassian: 217
  • NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

    Dimitar Efremov, Adrian Wiestner, Luca Laurenti
    e2012067
    2012-10-09
    https://doi.org/10.4084/mjhid.2012.067
    2474
    PDF: 835
    HTML: 8811
    Efremov 1: 222
    Efremov 2: 183
  • PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma

    Ugo Testa; Giuseppe G.M. Leone
    e2025005
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.005
    2437
    HTML: 268
    PDF: 863
  • THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

    Nicola Semeraro, Prof. Mario Colucci
    e2021045
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.045
    1947
    PDF: 809
    HTML: 219
  • NEW STRATEGIES FOR STEM CELL MOBILIZATION

    Roberto Lemoli
    e2012066
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.066
    2390
    PDF: 849
    HTML: 2452
  • SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

    Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci
    e2010024
    2010-08-06
    https://doi.org/10.4084/mjhid.2010.024
    3265
    PDF: 1648
    HTML: 4483
  • PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

    Anna Falanga, Laura Russo, Carmen J Tartari
    e2011068
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.068
    1792
    PDF: 799
    HTML: 10229
    Figures 1,2,3: 172
  • OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism

    Ugo Testa, Elvira Pelosi, Germana Castelli
    e2025067
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.067
    1849
    PDF: 916
    Html: 311
  • THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE

    Evi Stavrou, Hillard Michael Lazarus
    e2010033
    2010-10-29
    https://doi.org/10.4084/mjhid.2010.033
    1569
    PDF: 1045
    HTML: 10445
  • IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

    Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop
    e2009010
    2009-11-13
    https://doi.org/10.4084/mjhid.2009.010
    1156
    PDF: 600
    HTML: 6796
  • ADULT SICKLE CELL ANAEMIA PATIENTS IN BONE PAIN CRISIS HAVE ELEVATED PRO-INFLAMMATORY CYTOKINES

    Adekunle Emmanuel Alagbe, John Ayodele Olaniyi, Oladapo Wale Aworanti
    e2018017
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.017
    2937
    PDF: 900
    HTML: 406
  • PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

    Lucia De Franceschi
    e2009024
    2009-12-26
    1049
    PDF: 652
    HTML: 11077
  • PRENATAL DIAGNOSIS OF ?-THALASSEMIAS AND HEMOGLOBINOPATHIES

    Maria Cristina Rosatelli, Luisella Saba
    e2009011
    2009-11-15
    1183
    PDF: 373
    HTML: 6359
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    2710
    PDF: 3186
    HTML: 365
  • Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs

    Feiying Meng
    e2021041
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.041
    1105
    PDF: 483
    HTML: 226
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3658
    PDF: 1429
    HTML: 181
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2150
    PDF: 1465
    HTML: 262
  • PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

    Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus
    e2014053
    2014-07-04
    https://doi.org/10.4084/mjhid.2014.053
    3291
    PDF: 1953
    HTML: 7472
  • ON THE VERSATILITY OF VON WILLEBRAND FACTOR

    Antoine Rauch, Peter Lenting
    e2013046
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.046
    2776
    PDF: 1112
    HTML: 11215
  • Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio

    Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
    e2025006
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.006
    2149
    PDF: 1574
    HTML: 261
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1159
    PDF: 736
    HTML: 579
  • NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

    Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi
    e2019002
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.002
    6792
    PDF: 3636
    HTML: 749
  • CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

    Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda
    e2019067
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.067
    2849
    PDF: 1829
    HTML: 750
  • PLATELET-LEUKOCYTE INTERACTIONS : MULTIPLE LINKS BETWEEN INFLAMMATION , BLOOD COAGULATION AND VASCULAR RISK

    Chiara Cerletti, Giovanni de Gaetano, Roberto Lorenzet
    e2010023
    2010-08-06
    https://doi.org/10.4084/mjhid.2010.023
    1744
    PDF: 835
    HTML: 10385
  • PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

    Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro
    e2013058
    2013-09-01
    https://doi.org/10.4084/mjhid.2013.058
    3453
    PDF: 1156
    HTML: 24011
  • PROGNOSTIC VALUE OF PROTEASE ACTIVATED RECEPTOR-1 IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2014029
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.029
    1327
    PDF: 778
    HTML: 2256
  • EBV CHRONIC INFECTIONS

    Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti
    e2010022
    2010-08-09
    https://doi.org/10.4084/mjhid.2010.022
    3453
    PDF: 1569
    HTML: 7796
  • POEMS SYNDROME: AN UPDATE

    Andrea Nozza
    e2017051
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.051
    3273
    PDF: 1626
    HTML: 1500
  • Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells

    Dina Sameh Soliman, Hesham Elsabah, Ibrahim Ganwo, Aliaa Amer, Ruba Y Taha, Lajos Szabados , Mouhammad Sharaf Eldean, Ahmad Al-Sabbagh, Feryal Ibrahim
    e2021043
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.043
    1518
    PDF: 386
    HTML: 205
  • Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

    Bhavya S Doshi, Valder R Arruda, Valder R Arruda
    e2020069
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.069
    2030
    PDF: 1854
    HTML: 341
  • IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

    Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno
    e2009006
    2009-10-27
    1617
    PDF: 643
    HTML: 43902
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    4828
    PDF: 1959
    HTML: 8309
  • MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19

    XiaoTian Zhang, Yanhui Yu, Chao Zhang, Lijuan Zhao, Hongrui Wang, Guoqing Wang, Ming Yang
    e2022003
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.003
    1869
    PDF: 1071
    HTML: 295
  • IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME

    Rosangela Invernizzi, Federica Quaglia, Matteo Giovanni Della Porta
    e2015035
    2015-04-26
    https://doi.org/10.4084/mjhid.2015.035
    3278
    PDF: 2261
    HTML: 23318
    Untitled: 202
    Untitled: 214
    Untitled: 228
  • SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.

    Ilhami Berber, Ozlem Cagasar, Ahmet Sarıcı, Nurcan Kirici Berber, Ismet Aydogdu, Asli Yildirim, Harika Gozde Gocukara Bag, Leman Acun Delen, Ozkan Ulutas
    e2021009
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.009
    3231
    PDF: 1072
    HTML: 428
  • PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD

    Beatrice Autino, Yolanda Corbett, Francesco Castelli, Donatella Taramelli
    e2012061
    2012-10-04
    https://doi.org/10.4084/mjhid.2012.061
    4456
    PDF: 1914
    HTML: 17730
  • Molecular Expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinase plasma cellular disorders: a molecular panel to investigate disease progression

    Maria Cristina Rapanotti
    e2018059
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.059
    1311
    PDF: 761
    HTML: 150
  • VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS

    Anna M. Randi, Mike A Laffan, Richard D. Starke
    e2013060
    2013-09-02
    https://doi.org/10.4084/mjhid.2013.060
    3724
    PDF: 1557
    HTML: 8029
    Randi Fig: 177
  • THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.

    Sagir Gumel Ahmed
    e2011028
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.028
    5126
    PDF: 1313
    HTML: 2740
    Cover letter: 189
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    5506
    PDF: 2310
    HTML: 1325
  • EBV AND HHV-6 CIRCULATING SUBTYPES IN PEOPLE LIVING WITH HIV IN BURKINA FASO, IMPACT ON CD4 T CELL COUNT AND HIV VIRAL LOAD

    Lassina TRAORE, Ouéogo NIKIEMA, Abdoul Karim OUATTARA, Tegwindé Rébéca COMPAORE, Serge Théophile SOUBEIGA, Birama DIARRA, Dorcas OBIRI-YEBOAH, Pegdwendé Abel SORGHO, Florencia Wendkuuni DJIGMA, Cyrille BISSEYE, Albert Théophane YONLI, Jacques SIMPORE
    e2017049
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.049
    3270
    PDF: 1262
    HTML: 898
  • Guest Edtor: Pellegrino Musto NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

    Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani
    e2025027
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.027
    1384
    PDF: 1212
    HTML: 259
  • INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.

    M. Al Huneini, Anil Pathare
    e2017028
    2017-04-20
    https://doi.org/10.4084/mjhid.2017.028
    2044
    PDF: 912
    HTML: 1363
1 - 50 of 99 items 1 2 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy